Concepedia

Publication | Closed Access

Ledipasvir/sofosbuvir ± ribavirin for 12 or 24 weeks is safe and effective in children 6–11 years old with chronic hepatitis C infection

DOI

13

Citations

0

References

2017

Year

Karen F. Murray, William F. Balistreri, Sanjay Bansal, Suzanne Whitworth, Helen Evans, Regino P. González‐Peralta, Jessica Wen, Benedetta Massetto, Kathryn Kersey, Yu Zhu,
Journal of Hepatology

No additional data available for this publication yet. Check back later!